Clinical pharmacy questions test your ability to apply pharmaceutical knowledge to patient care decisions. They are the closest exam approximation to what you will do daily as a registered pharmacist — and they reward candidates who think systematically.
Most Frequently Tested Clinical Areas
Cardiovascular disease. Hypertension management (NICE NG136 — first-line by ethnicity and age, step-up protocol), heart failure (ACEi/ARB + beta-blocker + MRA, SGLT2 inhibitor addition), anticoagulation for AF (CHA₂DS₂-VASc score, DOAC vs warfarin), ACS (dual antiplatelet, statin, ACEi, beta-blocker). Diabetes. Insulin regimens (basal-bolus, mixed insulin, insulin titration), oral hypoglycaemics (metformin first-line, SGLT2 inhibitors for cardiovascular/renal benefit), monitoring (HbA1c targets, hypoglycaemia management), complications. Respiratory. Asthma stepwise management (NICE/BTS), COPD (inhaler selection, exacerbation management, oxygen therapy), inhaler technique considerations. Infection. Antibiotic selection by indication and guideline (community-acquired pneumonia, UTI, cellulitis, COPD exacerbation), duration, narrow vs broad spectrum, allergy alternatives. Mental health. Depression (SSRI first-line, monitoring, switching/augmentation), anxiety, psychosis (antipsychotic selection, monitoring for metabolic syndrome, QTc), bipolar disorder. Pain management. WHO analgesic ladder, opioid conversion, neuropathic pain (pregabalin, duloxetine, amitriptyline), NSAID contraindications.
Systematic Approach
For every clinical scenario: patient factors (age, comorbidities, renal/hepatic function, allergies, pregnancy) → drug factors (interactions, contraindications, side effects, monitoring) → condition factors (severity, guidelines compliance, comorbidities affecting management) → action (what do you recommend and why?).
Where Candidates Underperform
Complex polypharmacy scenarios — multiple conditions, multiple medications, cascading interactions. Multi-morbidity management — patient with diabetes + CKD + heart failure: which drugs need adjusting, which are contraindicated, which should be added? Therapeutic drug monitoring — when to check levels, how to interpret them, what to do with the result.